Diabetes - GLP-1 agonists should be primarily considered in patients with type 2 diabetes with suboptimal glycaemic control despite maximal tolerated dose of metformin (+/- other agents) especially where weight loss is desired and/or significant stroke risk is present
This makes it particularly effective for comprehensive anti-aging approaches
I also prefer semaglutide drugs over other weight loss drugs out there (for example, phentermine, a controlled substance that can be habit forming, or orlistat, a drug that results in fat malabsorption and disaster pants)
on the supposed aggravation of COVID-19 (Micallef et al., 2020a
If you are considering weight management, We offer a compassionate and experienced team to support you on your journey to better health
Taniya recalled that when she walked into the clinic, the staff asked for her budget and based on that selected an injection from a range of options